MeSH term | MeSH ID | Detail |
---|---|---|
Farber Lipogranulomatosis | D055577 | 1 associated lipids |
Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Lee HS et al. | Antigen-induced Ca2+ mobilization in RBL-2H3 cells: role of I(1,4,5)P3 and S1P and necessity of I(1,4,5)P3 production. | 2005 | Cell Calcium | pmid:16219349 |
Chalfant CE and Spiegel S | Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. | 2005 | J. Cell. Sci. | pmid:16219683 |
Rahaman M et al. | Neutrophil sphingosine 1-phosphate and lysophosphatidic acid receptors in pneumonia. | 2006 | Am. J. Respir. Cell Mol. Biol. | pmid:16224106 |
di Villa Bianca Rd et al. | Sphingosine 1-phosphate induces endothelial nitric-oxide synthase activation through phosphorylation in human corpus cavernosum. | 2006 | J. Pharmacol. Exp. Ther. | pmid:16234413 |
Stahelin RV et al. | The mechanism of membrane targeting of human sphingosine kinase 1. | 2005 | J. Biol. Chem. | pmid:16243846 |
Kim MY et al. | Sphingosine-1-phosphate activates BKCa channels independently of G protein-coupled receptor in human endothelial cells. | 2006 | Am. J. Physiol., Cell Physiol. | pmid:16267108 |
Katkade V et al. | Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through Akt. | 2005 | Thromb. Haemost. | pmid:16268479 |
Wei SH et al. | Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. | 2005 | Nat. Immunol. | pmid:16273098 |
Bu S et al. | Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. | 2006 | FASEB J. | pmid:16278291 |
Ozbay T et al. | Cyclic adenosine 5'-monophosphate-dependent sphingosine-1-phosphate biosynthesis induces human CYP17 gene transcription by activating cleavage of sterol regulatory element binding protein 1. | 2006 | Endocrinology | pmid:16306078 |
Saini HS et al. | Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. | 2005 | J. Neurochem. | pmid:16313513 |
Mizugishi K et al. | Essential role for sphingosine kinases in neural and vascular development. | 2005 | Mol. Cell. Biol. | pmid:16314531 |
Olivera A et al. | IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. | 2006 | J. Biol. Chem. | pmid:16316995 |
Kawamori T et al. | Sphingosine kinase 1 is up-regulated in colon carcinogenesis. | 2006 | FASEB J. | pmid:16319132 |
Roviezzo F et al. | Essential requirement for sphingosine kinase activity in eNOS-dependent NO release and vasorelaxation. | 2006 | FASEB J. | pmid:16322129 |
Der P et al. | Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts. | 2006 | J. Mol. Cell. Cardiol. | pmid:16337960 |
Gonzalez E et al. | Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells. | 2006 | J. Biol. Chem. | pmid:16339142 |
Kang JS et al. | Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways. | 2006 | Mol. Pharmacol. | pmid:16354764 |
Pchejetski D et al. | Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. | 2005 | Cancer Res. | pmid:16357178 |
von Otte S et al. | Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. | 2006 | J. Biol. Chem. | pmid:16365044 |
Park KS et al. | Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G-proteins. | 2006 | Mol. Pharmacol. | pmid:16368894 |
Kobayashi N et al. | Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. | 2006 | J. Lipid Res. | pmid:16371645 |
Kono M et al. | Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids. | 2006 | J. Biol. Chem. | pmid:16380386 |
Alewijnse AE and Michel MC | Sphingosine-1-phosphate and sphingosylphosphorylcholine: two of a kind? | 2006 | Br. J. Pharmacol. | pmid:16402045 |
Mathieson FA and Nixon GF | Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation. | 2006 | Br. J. Pharmacol. | pmid:16402047 |
Chantrain CF et al. | Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. | 2006 | Eur. J. Cancer | pmid:16406506 |
Gardell SE et al. | Emerging medicinal roles for lysophospholipid signaling. | 2006 | Trends Mol Med | pmid:16406843 |
Seol GH et al. | Sphingosine-1-phosphate-induced intracellular Ca2+ mobilization in human endothelial cells. | 2005 Sep-Dec | Endothelium | pmid:16410226 |
Tardieu D et al. | Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks. | 2006 | Chem. Biol. Interact. | pmid:16412405 |
Betito S and Cuvillier O | Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent manner. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16414356 |
Lee JF et al. | Sphingosine-1-phosphate signaling regulates lamellipodia localization of cortactin complexes in endothelial cells. | 2006 | Histochem. Cell Biol. | pmid:16416022 |
Wendler CC and Rivkees SA | Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development. | 2006 | Dev. Biol. | pmid:16434032 |
Jurisicova A et al. | Molecular requirements for doxorubicin-mediated death in murine oocytes. | 2006 | Cell Death Differ. | pmid:16439991 |
Barthomeuf C et al. | Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis. | 2006 | Free Radic. Biol. Med. | pmid:16458188 |
Bassi R et al. | Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors. | 2006 | Glia | pmid:16470810 |
Yatomi Y | Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. | 2006 | Curr. Pharm. Des. | pmid:16472149 |
Kurobe H et al. | CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. | 2006 | Immunity | pmid:16473829 |
Keller M et al. | Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries. | 2006 | FASEB J. | pmid:16476702 |
Naetzker S et al. | Activation of p38 mitogen-activated protein kinase and partial reactivation of the cell cycle by cis-4-methylsphingosine direct postmitotic neurons towards apoptosis. | 2006 | Genes Cells | pmid:16483315 |
Afrasiabi E et al. | Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C. | 2006 | Cell. Signal. | pmid:16490345 |
Choueiri TK et al. | Phenoxodiol: isoflavone analog with antineoplastic activity. | 2006 | Curr Oncol Rep | pmid:16507219 |
Kitano M et al. | Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. | 2006 | Arthritis Rheum. | pmid:16508938 |
Hsieh HL et al. | Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells. | 2006 | J. Cell. Physiol. | pmid:16508949 |
Becciolini L et al. | Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts. | 2006 | Biochim. Biophys. Acta | pmid:16510307 |
Song HJ et al. | Sphingosine 1-phosphate-induced signal transduction in cat esophagus smooth muscle cells. | 2006 | Mol. Cells | pmid:16511346 |
Takai S et al. | Phosphatidylinositol 3-kinase/Akt plays a role in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts. | 2006 | J. Cell. Biochem. | pmid:16514645 |
Wattenberg BW et al. | The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. | 2006 | J. Lipid Res. | pmid:16520486 |
Czyborra C et al. | Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine. | 2006 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:16521006 |
Sutherland CM et al. | The calmodulin-binding site of sphingosine kinase and its role in agonist-dependent translocation of sphingosine kinase 1 to the plasma membrane. | 2006 | J. Biol. Chem. | pmid:16522638 |
Fieber CB et al. | Modulation of total Akt kinase by increased expression of a single isoform: requirement of the sphingosine-1-phosphate receptor, Edg3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothelial cells. | 2006 | Exp. Cell Res. | pmid:16527273 |